| Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts |
Non-Interventional Study |
Recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer |
Fulvestrant, Letrozole, Palbociclib, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk |
Placebo, Questionnaire Administration, Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 4 mg/each breast/day |
Active, not recruiting |
| Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic |
Biospecimen Collection, Interview |
Active, not recruiting |
| Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries |
S5 DNA methylation classifier, Xpert HPV |
Recruiting |
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention |
omega 3 fatty acids |
Active, not recruiting |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients |
Megestrol Acetate, Olanzapine, Questionnaire Administration |
Recruiting |
| Obeticholic Acid for Prevention in Barrett's Esophagus |
Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic Acid, Placebo Administration, Questionnaire Administration |
Recruiting |
| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery |
Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs |
Screening with HPV test |
Recruiting |
